NCT06085690 Multicenter Clinical Translational Study of "ICU-NO CRBSI" Based on Improvement Science
| NCT ID | NCT06085690 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fudan University |
| Condition | CRBSI - Catheter Related Bloodstream Infection |
| Study Type | INTERVENTIONAL |
| Enrollment | 8,050 participants |
| Start Date | 2023-09-04 |
| Primary Completion | 2025-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 8,050 participants in total. It began in 2023-09-04 with a primary completion date of 2025-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this type of study is to construct the continuous quality promotion project "ICU-NO CRBSI(Catheter-Related Bloodstream Infection , CRBSI)" based on improvement science, and to verify its effect in the prevention of central venous catheter-related bloodstream infection and continuous quality improvement in ICU ( Intensive Care Unit , ICU) through multi-center implementation and two rounds of improvement. The main question\[s\] it aims to answer are: What is the incidence of catheter-related bloodstream infection in the ICU of participating units? How compliant are health care providers in the ICU with evidence-based sensory control practices for the prevention of catheter-associated bloodstream infection? Participants will be provided with the hospital's routine CVC (Central Venous Catheter ,CVC) care practices and CVC quality improvement measures based on evidence-based guidelines What technical and cultural support is needed to implement quality and safety improvement measures?
Eligibility Criteria
Inclusion Criteria: * ICU stay over 48 hours * CVC was placed for more than 24 hours Exclusion Criteria: * Pregnant patients * Patients with a history of CRBSI infection * Patients with central venous catheterization were brought in from other hospitals
Contact & Investigator
Yan Hu
STUDY CHAIR
School of Nursing, Fudan University; Center for Evidence-based Nursing, Fudan University
Frequently Asked Questions
Who can join the NCT06085690 clinical trial?
This trial is open to participants of all sexes, studying CRBSI - Catheter Related Bloodstream Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06085690 currently recruiting?
Yes, NCT06085690 is actively recruiting participants. Contact the research team at 21211170023@m.fudan.edu.cn for enrollment information.
Where is the NCT06085690 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06085690 clinical trial?
NCT06085690 is sponsored by Fudan University. The principal investigator is Yan Hu at School of Nursing, Fudan University; Center for Evidence-based Nursing, Fudan University. The trial plans to enroll 8,050 participants.